Armata Pharmaceuticals, Inc (ARMP) insider trading
Every open-market stock purchase and sale by Armata Pharmaceuticals, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- Last insider buy: Innoviva Inc. (10% owner), $592,105B, 3 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales).
Recent ARMP insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Apr 24, 2026 | Daniel B. Gilmer (Director) | Bought (not open market) | — |
| Mar 14, 2026 | Deborah Birx (CEO) | Sold (not open market) | $51.8K |
| Mar 14, 2026 | Pierre Kyme (C-suite exec) | Sold (not open market) | $10.9K |
| Mar 9, 2026 | David Duane House (VP) | Bought (not open market) | — |
| Mar 9, 2026 | Robin Kramer (Director) | Bought (not open market) | — |
| Mar 9, 2026 | Pierre Kyme (C-suite exec) | Bought (not open market) | — |
| Mar 9, 2026 | Kostas D Odysseas (Director) | Bought (not open market) | — |
| Mar 9, 2026 | Todd C. Peterson (Director) | Bought (not open market) | — |
| Mar 9, 2026 | Deborah Birx (CEO) | Bought (not open market) | — |
| Mar 9, 2026 | Sarah J. Schlesinger (Director) | Bought (not open market) | — |
| Mar 9, 2026 | Jules Haimovitz (Director) | Bought (not open market) | — |
| Mar 9, 2026 | Joseph M Patti (Director) | Bought (not open market) | — |
Who's trading ARMP
- Daniel B. Gilmer, Director: other filings, last Apr 24, 2026
- Deborah Birx, CEO: other filings, last Mar 14, 2026
- Pierre Kyme, C-suite exec: other filings, last Mar 14, 2026
- Jules Haimovitz, Director: other filings, last Mar 9, 2026
- Robin Kramer, Director: other filings, last Mar 9, 2026
- Sarah J. Schlesinger, Director: other filings, last Mar 9, 2026
- Kostas D Odysseas, Director: other filings, last Mar 9, 2026
- Joseph M Patti, Director: other filings, last Mar 9, 2026
- Todd C. Peterson, Director: other filings, last Mar 9, 2026
- David Duane House, VP: other filings, last Mar 9, 2026
Get free alerts when an insider at Armata Pharmaceuticals, Inc files a new trade →